beta-Secretase as a therapeutic target for Alzheimer's disease.
about
Recent developments in Alzheimer's disease therapeuticsDiverse molecular targets for therapeutic strategies in Alzheimer's diseaseAlzheimer's therapeutics: translation of preclinical science to clinical drug developmentComputational Insights into Substrate and Site Specificities, Catalytic Mechanism, and Protonation States of the Catalytic Asp Dyad of β -SecretaseTargeting mRNA for Alzheimer's and related dementias.Development and Structural Modification of BACE1 InhibitorsModulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanismsApplication of consensus scoring and principal component analysis for virtual screening against β-secretase (BACE-1)FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylationPepsin homologues in bacteriaIntegrating experimentation and quantitative modeling to enhance discovery of Beta amyloid lowering therapeutics for Alzheimer's disease.Beta-secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic mice.Enhanced red-emitting railroad worm luciferase for bioassays and bioimagingPredicting memapsin 2 (β-secretase) hydrolytic activity.Phospho-eIF2α level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD miceAlzheimer's disease biomarker discovery in symptomatic and asymptomatic patients: experimental approaches and future clinical applications.Targeting Abeta and tau in Alzheimer's disease, an early interim reportHarnessing nature's insight: design of aspartyl protease inhibitors from treatment of drug-resistant HIV to Alzheimer's disease.BACE1 inhibitory activity of fungal endophytic extracts from Malaysian medicinal plantsAlzPathway: a comprehensive map of signaling pathways of Alzheimer's disease.Exploring the binding of BACE-1 inhibitors using comparative binding energy analysis (COMBINE).Comparison of pharmacological modulation of APP metabolism in primary chicken telencephalic neurons and in a human neuroglioma cell lineTargets for AD treatment: conflicting messages from γ-secretase inhibitorsHigh glucose promotes Aβ production by inhibiting APP degradation.Structure-based design, synthesis and biological evaluation of novel β-secretase inhibitors containing a pyrazole or thiazole moiety as the P3 ligand.Novel in vitro inhibitory functions of potato tuber proteinaceous inhibitorsEffects of curcuminoids identified in rhizomes of Curcuma longa on BACE-1 inhibitory and behavioral activity and lifespan of Alzheimer's disease Drosophila models.In Silico Design of Beta-Secretase Inhibitors in Alzheimer's Disease.Developing β-secretase inhibitors for treatment of Alzheimer's disease.Cutting in on a secretase pas de deuxAn NSAID-like compound, FT-9, preferentially inhibits gamma-secretase cleavage of the amyloid precursor protein compared to its effect on amyloid precursor-like protein 1.Exploring novel mechanistic insights in Alzheimer's disease by assessing reliability of protein interactions.The Components of Flemingia macrophylla Attenuate Amyloid β-Protein Accumulation by Regulating Amyloid β-Protein Metabolic Pathway.Identification of novel acetylcholinesterase inhibitors through e-pharmacophore-based virtual screening and molecular dynamics simulations.Effects and possible mechanisms of action of acacetin on the behavior and eye morphology of Drosophila models of Alzheimer's disease.Regulation of cerebral cholesterol metabolism in Alzheimer disease.Alzheimer's disease and blood-brain barrier function-Why have anti-beta-amyloid therapies failed to prevent dementia progression?Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma.A large and accurate collection of peptidase cleavages in the MEROPS database.Novel strategies for the prevention of dementia from Alzheimer's disease.
P2860
Q21245264-A41B4C9E-E91C-4846-A8EC-A72FAB233840Q26827193-420B6112-518E-4E77-9297-53EC1BD2DB65Q26829267-6ECD924F-CD39-4E79-A6D2-36B13218236CQ27026144-66CE581E-A5C9-47A0-9A47-D35F42D66C55Q27687153-802CAC13-329B-4B4C-9A0E-B78D6956C770Q28068099-4305710D-C6C5-4D24-A50E-207F7EEC1446Q28259424-EC9C76E3-7680-4AA1-BC04-73ED883C9D61Q28484175-8248B43D-9E1D-4C1B-B835-210833DE920AQ28534810-474813A5-A536-49CB-8418-2892555B6015Q28750549-CD8946B4-4FA1-49E1-ADE8-3245DC0D2E83Q30422271-9E068E08-7F97-4648-BBDA-5866827C0C05Q30497942-ED0719B2-B292-43F5-BBA5-56D1F049A99DQ33635210-8EFA62BE-7593-4166-8D08-6F03AF33D988Q33696172-C4337289-656A-4A10-B45A-E05158F85B8BQ33707706-714CA11C-BCAF-4E31-80A3-9F48E161A5A9Q33736582-CF4A28CE-E7CA-4955-A0F4-B4E9E4405E16Q33829008-F9DA4C64-2247-4085-9A9E-81F9E1BED63AQ33870886-CEEF7308-70B0-4C75-B0D3-9463CB701851Q34029099-DEE9C845-1B97-4B69-A7B3-71A2221BF13AQ34286579-8AF51A01-7362-456E-9957-189E8DDE91D4Q34394583-49F29E2D-2C59-4546-84E2-3BCB9C972FCEQ34586941-48D6E3E8-3A3C-42CC-B484-5A7F2E5A325BQ34792043-1707DF3B-541C-41F9-839F-58F68CBD5199Q34874591-1ED9AFC5-29F3-4DA7-A363-086315A3DD53Q34979594-88FCD11E-C6EC-466E-B8DE-4FB4C400CA07Q35024735-D30C8BE1-345D-4232-B02E-1030CC57B41EQ35111820-663E9FF2-E9C4-40B0-8FBC-80E67D190AB3Q35491990-1BC001CB-7B6E-4AED-9D6D-13875888EB7BQ35746998-3E7E23C1-CF7F-407E-B8E9-AAA00F50BDBDQ35769880-F95AC979-A8EA-422D-8021-8D2D59D51F9FQ35809939-61368628-BA59-4D9D-B3E0-32F6634FB2B8Q36034936-325FB117-F072-42DA-9C68-313604175172Q36036555-3E7F1663-A46C-4E41-A805-3801DF76C27AQ36174613-35352F2F-42BA-48D2-8A3F-86735B4C3DBBQ36245937-C20AB84A-8BCC-4708-A7C4-DF5F8E11DCB0Q36841850-96357961-BCD6-4B45-9798-A144A884D1A9Q37253310-F3B98ED8-328B-4C71-A737-BD3B89D20220Q37446487-FFEA9CDE-ECA8-48B4-874E-C75D17388F29Q37465276-E3153B46-6F7D-4FB6-82F3-6729F6A61259Q37544750-F94C8CD6-C5E2-415C-88E8-8CC38CE106AD
P2860
beta-Secretase as a therapeutic target for Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
beta-Secretase as a therapeutic target for Alzheimer's disease.
@en
beta-Secretase as a therapeutic target for Alzheimer's disease.
@nl
type
label
beta-Secretase as a therapeutic target for Alzheimer's disease.
@en
beta-Secretase as a therapeutic target for Alzheimer's disease.
@nl
prefLabel
beta-Secretase as a therapeutic target for Alzheimer's disease.
@en
beta-Secretase as a therapeutic target for Alzheimer's disease.
@nl
P2093
P2860
P1433
P1476
beta-Secretase as a therapeutic target for Alzheimer's disease.
@en
P2093
Arun K Ghosh
Jordan Tang
Sandra Gemma
P2860
P2888
P304
P356
10.1016/J.NURT.2008.05.007
P577
2008-07-01T00:00:00Z
P5875
P6179
1010986901